Mondelēz recalls RITZ crackers due to peanut allergy risk

Published 08/07/2025, 16:22
Mondelēz recalls RITZ crackers due to peanut allergy risk

EAST HANOVER, N.J. - Mondelēz Global LLC (NASDAQ:MDLZ), an $88.6 billion market cap consumer goods giant with annual revenues exceeding $36 billion, has initiated a voluntary recall of specific RITZ Peanut Butter Cracker Sandwich products due to incorrect labeling that poses risks to consumers with peanut allergies, the company announced Tuesday. According to InvestingPro analysis, the company maintains a GOOD overall financial health score, suggesting strong operational resilience to manage such challenges.

The recall affects four carton sizes of RITZ products sold nationwide: 8-pack, 20-pack, and 40-pack cartons of RITZ Peanut Butter Cracker Sandwiches, as well as the 20-pack RITZ Filled Cracker Sandwich Variety Pack. According to the company statement, some individually wrapped packs inside these cartons may be incorrectly labeled as cheese variety despite containing peanut butter.

The affected products have "Best When Used By" dates ranging from November 1-9, 2025, and January 2-22, 2026, with specific plant codes AE, AM, or RJ located on the packaging.

While the outer cartons are correctly labeled with peanut allergen warnings, the mislabeled inner packages could present serious health risks to individuals with peanut allergies who might consume the product believing it to be cheese-flavored.

Mondelēz (NASDAQ:MDLZ) stated the recall was initiated after discovering defects in film packaging rolls used for individually wrapped products, attributable to a supplier error. The company has implemented corrective measures to prevent recurrence.

No injuries or illnesses related to the mislabeled products have been reported to date. The recall is being conducted with the knowledge of the U.S. Food and Drug Administration. With the company’s next earnings report scheduled for July 29, investors following this development can access comprehensive analysis and additional insights through InvestingPro’s detailed research reports, which cover over 1,400 US stocks including Mondelēz.

Consumers with peanut allergies are advised not to consume the affected products and to discard them. The company has established a 24/7 contact line at 1-844-366-1171 for consumers seeking additional information about the recall.

Products not listed in the recall, including cartons containing only RITZ Cheese Cracker Sandwiches and those with different expiration dates or plant codes, are not affected by this recall, according to the press release statement. Despite recent market volatility, Mondelēz has demonstrated resilience with a 19.7% price return over the past six months and maintains a conservative beta of 0.49, indicating lower volatility compared to the broader market. Based on InvestingPro’s Fair Value analysis, the stock currently appears fairly valued.

In other recent news, Mondelez International reported its first-quarter results for 2025, showcasing an organic growth rate of 3.1%, which was slightly below the expected 3.5%. Despite this, the company saw a significant increase in pricing, rising to 6.6% and surpassing the consensus estimate of 4.8%. The adjusted earnings per share (EPS) came in at $0.74, exceeding the consensus estimate of $0.66, although it represented a 23% decline from the previous year. Mondelez’s adjusted earnings before interest and taxes (EBIT) margins contracted by 360 basis points, leading to a 20% decrease in adjusted EBIT, which still outperformed the consensus forecast. Several financial firms, including Berenberg, Stifel, BofA Securities, and Evercore ISI, have recently adjusted their price targets for Mondelez stock, reflecting optimism about the company’s future performance despite challenges such as high cocoa costs.

Berenberg raised the price target to $81, maintaining a Buy rating, while Stifel increased its target to $73, also keeping a Buy rating. BofA Securities updated its target to $75, citing stronger-than-expected earnings, and Evercore ISI lifted its target to $73, highlighting foreign exchange benefits and the company’s effective handling of cocoa costs. Mondelez has confirmed it will maintain its guidance for the full year 2025, projecting a 10% decline in EPS on a constant currency basis. Analysts have noted that Mondelez’s strategic pricing actions in Europe have been effective, contributing positively to the company’s earnings performance. Additionally, Mondelez announced a new severance plan for key executives, outlining benefits in the event of termination without cause or resignation for good reason, which will be detailed in the company’s upcoming 10-Q filing.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.